Treatment of chronic myelogenous leukemia, resistant or intolerant to sti571, involving homoharringtonine alone or combined with other agents
A Standard patent application filed on 05 September 2002 credited to Mahon, Francois-Xavier
;
Maloisel, Frederick
;
Blanchard, Julie
;
Robin, Jean-Pierre
;
Maisonneuve, Herve
Details
Application number :
2002337410
Application type :
Standard
Application status :
LAPSED
Under opposition :
No
Proceeding type :
Invention title :
Treatment of chronic myelogenous leukemia, resistant or intolerant to sti571, involving homoharringtonine alone or combined with other agents